日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial

在未接受过抗PD-1治疗的头颈部鳞状细胞癌患者中,病灶内注射SD-101联合帕博利珠单抗的疗效:一项多中心II期试验的结果

Cohen, Ezra E W; Nabell, Lisle; Wong, Deborah J; Day, Terry; Daniels, Gregory A; Milhem, Mohammed; Deva, Sanjeev; Jameson, Michael; Guntinas-Lichius, Orlando; Almubarak, Mohammed; Strother, Matthew; Whitman, Eric; Chisamore, Michael; Obiozor, Cynthia; Bagulho, Teresa; Gomez-Romo, Jose; Guiducci, Cristiana; Janssen, Robert; Gamelin, Erick; Algazi, Alain P